Corcept Therapeutics Incorporated (CORT)

Corcept Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 17, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,902	5,280	3,348	2,186	2,097	3,039
Market Cap Growth	60.84%	57.69%	53.13%	4.24%	-30.98%	119.78%
Enterprise Value	7,384	4,739	2,933	1,787	1,603	2,598
Last Close Price	75.12	50.39	32.48	20.31	19.80	26.16
PE Ratio	86.00	37.78	31.74	21.59	18.64	28.67
Forward PE	72.06	32.11	32.61	19.95	21.01	32.91
PS Ratio	10.53	7.82	6.94	5.44	5.73	8.59
PB Ratio	12.50	7.77	6.61	4.36	5.58	5.81
P/TBV Ratio	12.50	7.77	6.61	4.36	5.58	5.81
P/FCF Ratio	48.45	26.95	26.38	18.23	12.53	20.16
P/OCF Ratio	48.36	26.66	26.36	18.17	12.49	20.00
EV/Sales Ratio	9.96	7.02	6.08	4.45	4.38	7.34
EV/EBITDA Ratio	110.68	34.40	27.08	15.69	12.73	20.18
EV/EBIT Ratio	112.61	34.60	27.34	15.87	12.88	20.26
EV/FCF Ratio	45.27	24.19	23.12	14.90	9.58	17.24
Debt / Equity Ratio	0.01	0.01	0	0.00	0.00	0.01
Debt / EBITDA Ratio	0.09	0.05	0.00	0.01	0.00	0.02
Debt / FCF Ratio	0.04	0.04	0.00	0.01	0.00	0.02
Asset Turnover	0.92	0.92	0.80	0.80	0.74	0.72
Inventory Turnover	1.31	1.08	0.94	0.97	1.07	1.08
Quick Ratio	2.85	3.11	4.05	6.60	5.31	9.86
Current Ratio	3.14	3.35	4.39	6.89	5.61	10.07
Return on Equity (ROE)	16.70%	23.81%	21.05%	23.11%	25.03%	23.70%
Return on Assets (ROA)	5.10%	11.71%	11.13%	13.98%	15.63%	16.29%
Return on Capital (ROIC)	6.38%	14.34%	13.28%	16.01%	17.25%	17.79%
Return on Capital Employed (ROCE)	10.10%	19.60%	20.80%	22.00%	33.10%	24.50%
Earnings Yield	1.32%	2.67%	3.17%	4.64%	5.36%	3.49%
FCF Yield	2.06%	3.71%	3.79%	5.48%	7.98%	4.96%
Buyback Yield / Dilution	-7.55%	-1.55%	3.64%	7.94%	-1.42%	-1.33%

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q